CureVac N.V.
NASDAQ:CVAC
3.59 (USD) • At close May 8, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 535.18 | 53.758 | 67.42 | 102.99 | 48.9 | 17.416 | 12.871 |
| Kosten van de omzet
| 105.829 | 124.366 | 183.993 | 238.195 | 14.173 | 27.983 | 17.744 |
| Brutowinst
| 429.351 | -70.608 | -116.573 | -135.205 | 34.727 | -10.567 | -4.873 |
| Brutowinstmarge
| 0.802 | -1.313 | -1.729 | -1.313 | 0.71 | -0.607 | -0.379 |
| Onderzoek- en ontwikkelingskosten
| 153.034 | 115.724 | 62.55 | 815.907 | 113.808 | 43.242 | 41.722 |
| Algemene en administratieve kosten
| 56.375 | 76.009 | 88.994 | 87.201 | 45.029 | 42.183 | 20.415 |
| Verkoop- en marketingkosten
| 4.447 | 0.424 | 0.417 | 1.743 | 0.733 | 1.755 | 1.085 |
| Verkoop-, algemene en administratieve kosten
| 60.822 | 76.433 | 89.411 | 88.944 | 45.762 | 43.938 | 21.5 |
| Overige kosten
| 37.813 | 11.442 | -17.682 | -627.793 | -0.87 | 1.75 | 4.729 |
| Bedrijfskosten
| 251.669 | 203.599 | 134.279 | 277.058 | 158.7 | 88.93 | 67.951 |
| Bedrijfsresultaat
| 177.682 | -274.207 | -249.457 | -412.263 | -124.002 | -99.498 | -72.824 |
| Bedrijfsresultaat ratio
| 0.332 | -5.101 | -3.7 | -4.003 | -2.536 | -5.713 | -5.658 |
| Totaal overige inkomsten en kosten netto
| 13.199 | 14.238 | 0.302 | -0.235 | -20.033 | -0.627 | 1.693 |
| Inkomen voor belasting
| 190.881 | -259.969 | -249.155 | -412.498 | -129.8 | -100.125 | -71.131 |
| Inkomen voor belasting ratio
| 0.357 | -4.836 | -3.696 | -4.005 | -2.654 | -5.749 | -5.526 |
| Belastingkosten
| 28.695 | 0.198 | -0.126 | -0.782 | -0.726 | -0.252 | 0.11 |
| Nettowinst
| 162.186 | -260.167 | -249.029 | -411.716 | -129.074 | -99.873 | -71.241 |
| Nettowinstmarge
| 0.303 | -4.84 | -3.694 | -3.998 | -2.64 | -5.735 | -5.535 |
| WPA (Winst Per Aandeel)
| 0.72 | -1.18 | -1.32 | -2.21 | -0.98 | -0.53 | -0.4 |
| Verwaterde WPA
| 0.72 | -1.18 | -1.32 | -2.21 | -0.98 | -0.53 | -0.4 |
| EBITDA
| 209.69 | -234.09 | -209.386 | -386.486 | -123.095 | -91.501 | -69.851 |
| EBITDA ratio
| 0.392 | -4.355 | -3.106 | -3.753 | -2.517 | -5.254 | -5.427 |